Piperazine
These substances were identified for action under the Chemicals Management Plan (CMP).
Information sheet
CAS RN | DSL name | Draft screening assessment | Proposed conclusion on section 64 criteria | Follow-up activities |
---|---|---|---|---|
110-85-0 | Piperazine | HTML | Does not meet | None planned at this time |
Follow-up activities
Although a risk to human health or the environment has not been identified at current levels of exposure, there may be a concern if exposure to this substance were to increase. As a result, program officials may consider this substance in future initiatives to track its commercial status and/or any new uses.
Date | Activity |
---|---|
March 2022 | Anticipated publication of the final screening assessment. |
March 13, 2021 | Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 11. |
Page details
- Date modified: